Metabolite-driven antitumor immunity.
Where this comes from
- Record sourced from PubMed, PMID 36173838.
- Also identified by DOI 10.1126/science.ade3697.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
An oncometabolite blocks T cell killing by inhibiting glycolysis.
Medical subject headings
- CD8-Positive T-Lymphocytes
- Glutarates
- Glycolysis
- Neoplasms